{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T22:45:50Z","timestamp":1786229150965,"version":"build-2736575974"},"reference-count":19,"publisher":"SAGE Publications","issue":"6","license":[{"start":{"date-parts":[[2024,5,31]],"date-time":"2024-05-31T00:00:00Z","timestamp":1717113600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Public Health Rep"],"published-print":{"date-parts":[[2024,11]]},"abstract":"<jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>Linkage to HIV medical care is important in the continuum of HIV care and health outcomes for people with HIV. The objective of this analysis was to identify how the community-based organization (CBO) program contributes to linkage to HIV medical care among people with newly diagnosed HIV in the Centers for Disease Control and Prevention\u2019s (CDC\u2019s) HIV testing program.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>We analyzed HIV linkage-to-care data submitted to CDC from 2019 through 2021. Linkage was defined as confirmation that an individual attended their first HIV medical care appointment within 30 days of their HIV test date. We included in the analysis data submitted from the health department (HD) program that included 61 state and local HDs in the United States, Puerto Rico, and the US Virgin Islands and the CBO program that included 150 CBOs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>The CBO program linked a higher proportion of people to HIV medical care within 30 days of diagnosis (86.7%) than the HD program (73.7%). By population group, the proportion linked in the CBO program was higher than the proportion linked in the HD program among men who have sex with men (prevalence ratio [PR]\u2009=\u20091.13; P\u2009&lt;\u2009.001), men who have sex with men\/people who inject drugs (PR\u2009=\u20091.29; P\u2009&lt;\u2009.001), transgender people (PR\u2009=\u20091.28; P\u2009&lt;\u2009.001), and those reporting no sexual contact or injection drug use (PR\u2009=\u20091.34; P\u2009&lt;\u2009.001). In the Cox proportional hazards model, time to linkage in the CBO program was significantly shorter than in the HD program (hazard ratio\u2009=\u20090.63; P\u2009&lt;\u2009.001).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>This analysis shows that the CBO program fills a vital need in linking newly diagnosed HIV-positive people to HIV medical care, which is important in the HIV care continuum and for viral suppression.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/00333549241252579","type":"journal-article","created":{"date-parts":[[2024,5,31]],"date-time":"2024-05-31T04:53:12Z","timestamp":1717131192000},"page":"662-668","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":1,"title":["Contributions of the Community-Based Organization Program Funded by the Centers for Disease Control and Prevention to Linkage to HIV Medical Care"],"prefix":"10.1177","volume":"139","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5590-0327","authenticated-orcid":false,"given":"Mariette","family":"Marano-Lee","sequence":"first","affiliation":[{"name":"Translation and Evaluation Branch, Division of HIV Prevention, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weston","family":"Williams","sequence":"additional","affiliation":[{"name":"Public Health Analytic Consulting Services, Inc, Durham, NC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songli","family":"Xu","sequence":"additional","affiliation":[{"name":"Translation and Evaluation Branch, Division of HIV Prevention, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonny","family":"Andia","sequence":"additional","affiliation":[{"name":"Translation and Evaluation Branch, Division of HIV Prevention, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekaterine","family":"Shapatava","sequence":"additional","affiliation":[{"name":"Translation and Evaluation Branch, Division of HIV Prevention, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2024,5,31]]},"reference":[{"key":"bibr1-00333549241252579","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2019.1343"},{"key":"bibr2-00333549241252579","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1105243"},{"key":"bibr3-00333549241252579","unstructured":"The White House. National HIV\/AIDS strategy for the United States 2022-2025. 2021. Accessed February 20, 2024. https:\/\/www.whitehouse.gov\/wp-content\/uploads\/2021\/11\/National-HIV-AIDS-Strategy.pdf"},{"key":"bibr4-00333549241252579","volume-title":"CDC-Funded HIV Testing in the United States, Puerto Rico, and U.S. Virgin Islands","author":"Centers for Disease Control and Prevention","year":"2019"},{"key":"bibr5-00333549241252579","unstructured":"Centers for Disease Control and Prevention, National Center for HIV, Viral Hepatitis, STD, and TB Prevention. Funding opportunity announcement (FOA) PS18-1802: integrated human immunodeficiency virus (HIV) surveillance and prevention programs for health departments. 2019. Accessed February 20, 2024. https:\/\/www.cdc.gov\/hiv\/funding\/announcements\/ps18-1802\/index.html"},{"key":"bibr6-00333549241252579","unstructured":"National Center for HIV, Viral Hepatitis, STD, and TB Prevention. Notice of funding opportunity PS21-2102: comprehensive high-impact HIV prevention programs for community-based organizations. 2021. Accessed February 20, 2024. https:\/\/cdc.gov\/hiv\/funding\/announcements\/ps21-2102\/index.html"},{"key":"bibr7-00333549241252579","unstructured":"National Center for HIV, Viral Hepatitis, STD, and TB Prevention. Notice of funding opportunity PS22-2203: comprehensive high-impact HIV prevention programs for young men of color who have sex with men and young transgender persons of color. 2022. Accessed February 20, 2024. https:\/\/www.cdc.gov\/hiv\/funding\/announcements\/ps22-2203\/index.html"},{"issue":"6","key":"bibr8-00333549241252579","first-page":"702","volume":"106","author":"Bailey ME.","year":"1991","journal-title":"Public Health Rep"},{"key":"bibr9-00333549241252579","doi-asserted-by":"publisher","DOI":"10.1089\/apc.2022.0093"},{"key":"bibr10-00333549241252579","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.2021.306688"},{"key":"bibr11-00333549241252579","doi-asserted-by":"publisher","DOI":"10.1097\/PHH.0000000000001446"},{"key":"bibr12-00333549241252579","unstructured":"US Census Bureau, Geography Division. Census regions and divisions of the United States. 2013. Accessed February 20, 2024. https:\/\/www2.census.gov\/geo\/pdfs\/maps-data\/maps\/reference\/us_regdiv.pdf"},{"key":"bibr13-00333549241252579","doi-asserted-by":"publisher","DOI":"10.1097\/01.aids.0000161772.51900.eb"},{"key":"bibr14-00333549241252579","doi-asserted-by":"publisher","DOI":"10.1089\/apc.2007.9987"},{"key":"bibr15-00333549241252579","doi-asserted-by":"publisher","DOI":"10.1177\/00333549211029971"},{"key":"bibr16-00333549241252579","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciu357"},{"key":"bibr17-00333549241252579","doi-asserted-by":"publisher","DOI":"10.2105\/ajph.89.3.336"},{"key":"bibr18-00333549241252579","doi-asserted-by":"publisher","DOI":"10.1089\/108729101753205694"},{"key":"bibr19-00333549241252579","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-021-10449-w"}],"container-title":["Public Health Reports\u00ae"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/00333549241252579","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/00333549241252579","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/00333549241252579","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T09:39:43Z","timestamp":1777628383000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/00333549241252579"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,31]]},"references-count":19,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["10.1177\/00333549241252579"],"URL":"https:\/\/doi.org\/10.1177\/00333549241252579","relation":{},"ISSN":["0033-3549","1468-2877"],"issn-type":[{"value":"0033-3549","type":"print"},{"value":"1468-2877","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,31]]}}}